Searched for
SENORES PHARMA
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
Stock Radar: Investors book profits in Senores Pharma after hitting record high in July 2025; should you buy the dip?Senores Pharmaceuticals, part of the BSE Smallcap index, is showing bullish signals after a Cup pattern breakout in July 2025. Experts sugg...
8 smallcap stocks rally up to 50% after June quarter results daySmallcap stocks see a rise in share prices after strong June quarter results. Eight stocks rally between 10% and 50%. Vimta Labs, Infobeans...
Senores Pharma shares in focus after deal to acquire USFDA-approved epilepsy drug from WockhardtSenores Pharmaceuticals is set to acquire Wockhardt's USFDA-approved ANDA for Topiramate tablets, a medication used for epilepsy and migrai...
Senores Pharma to acquire 14 ANDAs from Dr Reddy's LaboratoriesSenores Pharmaceuticals of Gujarat has signed an agreement to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories. Th...
Stock market update: Nifty Pharma index advances 0.64%The Nifty Pharma index closed 0.64 per cent up at 22009.05.
Stock market update: Nifty Pharma index advances 0.44% in a weak marketThe Nifty Pharma index was trading 0.44 per cent up at 21965.65.
Stock market update: Nifty Pharma index 2.13%The Nifty Pharma index closed 2.13 per cent at 21903.35.
Kothari Products announces 1:1 bonus share issue, stock up 7%Kothari Products announced a 1:1 bonus share issue, causing a 7.4% stock rise to Rs 209.70. The issuance will be financed from free reserve...
JSW Energy shares zoom nearly 8% on signing Rs 12,468 cr definitive agreement with O2 PowerJSW Energy Share Price: Shares of JSW Energy rose 7.7% as its subsidiary JSW Neo Energy signed a definitive agreement to acquire O2 Power's...
Senores Pharma shares list at 53% premium over IPO priceSenores Pharmaceuticals’ shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to the IPO, whic...
Senores Pharmaceuticals IPO: Check allotment status, GMP, listing date and other detailsSenores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's we...
Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key detailsSenores Pharma's IPO subscription was oversubscribed at 93.41 times driven by retail, non-institutional, and qualified institutional buyers...
Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price bandRetail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times. Qualified institutio...
Senores Pharma IPO subscribed 1.8 times on Day 1: Check key dates, price band, GMP and reviewSenores Pharmaceuticals' IPO received 1.8 times subscription on its opening day, driven primarily by retail investors, who oversubscribed b...
Senores Pharma has niche positives, can be a long-term betIncorporated in 2017, the company identifies, develops and commercialises speciality and complex niche products in mid-market range. It als...
Senores Pharmaceuticals collects Rs 261 cr from anchor investorsSenores Pharmaceuticals Ltd on Thursday said it has secured nearly Rs 261 crore from anchor investors, ahead of its initial share-sale open...
Senores Pharmaceuticals sets price band at Rs 372-391 for Rs 582 crore IPO. Check detailsAhmedabad-based Senores Pharmaceuticals is set to launch its IPO on December 20, with a price band of Rs 372-391. The issue includes a fres...
Sebi green lights issues of Sagility, Senores PharmaWhen a company receives a final observation from Sebi, it’s a signal from the regulator to go ahead with the IPO process.
- Aurobindo Pharma to divest Chinese arm
Hyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...